These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

270 related articles for article (PubMed ID: 25808626)

  • 1. Safety and Effectiveness of Highly Active Antiretroviral Therapy in Treatment-Naïve HIV Patients: Preliminary Findings of a Cohort Event Monitoring Study in Belarus.
    Setkina S; Dotsenko M; Bondar S; Charnysh I; Kuchko A; Kaznacheeva A; Kozorez E; Dodaleva A; Rossa N
    Drug Saf; 2015 Apr; 38(4):365-72. PubMed ID: 25808626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A prospective study of highly active antiretroviral therapy in Indian human immunodeficiency virus positive patients.
    Rajesh R; Vidyasagar S; Varma DM; Naik A; Hegde BM; Guddattu V; Kamath A
    Int J Risk Saf Med; 2013 Jan; 25(1):53-65. PubMed ID: 23442298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pharmacovigilance study of adults on highly active antiretroviral therapy, South Africa: 2007 - 2011.
    Dube NM; Summers R; Tint KS; Mayayise G
    Pan Afr Med J; 2012; 11():39. PubMed ID: 22593775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association Between the Occurrence of Adverse Drug Events and Modification of First-Line Highly Active Antiretroviral Therapy in Ghanaian HIV Patients.
    Tetteh RA; Nartey ET; Lartey M; Mantel-Teeuwisse AK; Leufkens HG; Yankey BA; Dodoo AN
    Drug Saf; 2016 Nov; 39(11):1139-1149. PubMed ID: 27638659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Comparison of Adverse Drug Reaction Profiles in Patients on Antiretroviral and Antitubercular Treatment in Zimbabwe.
    Masuka JT; Chipangura P; Nyambayo PP; Stergachis A; Khoza S
    Clin Drug Investig; 2018 Jan; 38(1):9-17. PubMed ID: 28965312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adverse effects after HAART Initiation in resource-limited settings: a prospective study from Mysore, India.
    Sreenivasan S; Dasegowda V
    J Infect Dev Ctries; 2010 Nov; 4(11):750-3. PubMed ID: 21252454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of adverse drug reactions on treatment success: prospective cohort analysis of HIV-infected individuals initiating first-line antiretroviral therapy in India.
    Shet A; Antony J; Arumugam K; Kumar Dodderi S; Rodrigues R; DeCosta A
    PLoS One; 2014; 9(3):e91028. PubMed ID: 24614165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sentinel site active surveillance of safety of first-line antiretroviral medicines in Namibia.
    Mann M; Mengistu A; Gaeseb J; Sagwa E; Mazibuko G; Baeten JM; Babigumira JB; Garrison LP; Stergachis A
    Pharmacoepidemiol Drug Saf; 2016 Sep; 25(9):1052-60. PubMed ID: 27134056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse drug reactions of Highly Active Antiretroviral Therapy (HAART) in HIV infected patients at the General Hospital, Douala, Cameroon: a cross sectional study.
    Namme Luma H; Doualla MS; Choukem SP; Temfack E; Ashuntantang G; Achu Joko H; Koulla-Shiro S
    Pan Afr Med J; 2012; 12():87. PubMed ID: 23077708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adverse drug reaction monitoring in patients on antiretroviral therapy in a tertiary care hospital in Eastern India.
    Mukherjee S; Era N; Saha B; Tripathi SK
    Indian J Pharmacol; 2017; 49(3):223-228. PubMed ID: 29033481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of Adverse Drug Reactions to Highly Active Antiretroviral Therapy (HAART) among HIV Positive Patients in Imam Khomeini Hospital of Tehran, Iran.
    Koochak HE; Babaii A; Pourdast A; Golrokhy R; Rasoolinejad M; Khodaei S; Moghadam SRJ; Taheri RR; Seyed Alinaghi SA
    Infect Disord Drug Targets; 2017; 17(2):116-119. PubMed ID: 28164754
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
    Van Vaerenbergh K
    Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Safety study of 52-week highly active antiretroviral therapy in 198 HIV/AIDS Chinese patients].
    Li WJ; Dai Y; Han Y; Qiu ZF; Xie J; Zuo LY; Li YL; Li TS
    Zhonghua Yi Xue Za Zhi; 2011 May; 91(19):1318-22. PubMed ID: 21756757
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of maraviroc vs. efavirenz in treatment-naive patients with HIV-1: 5-year findings.
    Cooper DA; Heera J; Ive P; Botes M; Dejesus E; Burnside R; Clumeck N; Walmsley S; Lazzarin A; Mukwaya G; Saag M; van Der Ryst E
    AIDS; 2014 Mar; 28(5):717-25. PubMed ID: 24983542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Consensus document of Gesida and Spanish Secretariat for the National Plan on AIDS (SPNS) regarding combined antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2012)].
    Panel de expertos de Gesida y Plan Nacional sobre el Sida
    Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):e1-89. PubMed ID: 22633764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advances in pharmacovigilance of antiretroviral therapy in HIV-infected and exposed children.
    Kenny J; Musiime V; Judd A; Gibb D
    Curr Opin HIV AIDS; 2012 Jul; 7(4):305-16. PubMed ID: 22678488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HAART induced adverse drug reactions: a retrospective analysis at a tertiary referral health care center in India.
    Anwikar SR; Bandekar MS; Smrati B; Pazare AP; Tatke PA; Kshirsagar NA
    Int J Risk Saf Med; 2011; 23(3):163-9. PubMed ID: 22020396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reporting and recording of adverse drug reactions of highly active antiretroviral therapy by HIV infected patients and healthcare professionals respectively in the Ethekwini Metropolitan of Kwa-Zulu Natal, South Africa: a cross-sectional and retrospective comparative study.
    Zondi SL; Naidoo P
    Pan Afr Med J; 2022; 42():218. PubMed ID: 36845236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Retrospective Review of Serious Adverse Drug Reaction Reports in the Nigerian VigiFlow Database from September 2004 to December 2016.
    Ogar CK; Abiola A; Yuah D; Ibrahim A; Oreagba IA; Amadi EC; Adeyeye MC; Oshikoya KA
    Pharmaceut Med; 2019 Apr; 33(2):145-157. PubMed ID: 31933250
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
    McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
    Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.